Gut microbiome supplementation as therapy for metabolic syndrome

doi:10.4239/wjd.v14.i10.1502

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4578)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

114

WORD

HTML

3219

Figures (1-4)

250

Tables (1-2)

257

Sum=3883

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

144

Download

318

Sum=462

Oct 15, 2023 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Oct 15, 2023; 14(10): 1502-1513
Published online Oct 15, 2023. doi: 10.4239/wjd.v14.i10.1502

Full Size Figure Download Figure

Figure 3 The beneficial effects of postbiotics on metabolic syndrome. Treg: Regulatory T cell; SCFAs: Short Chain Fatty Acids.

Citation: Antony MA, Chowdhury A, Edem D, Raj R, Nain P, Joglekar M, Verma V, Kant R. Gut microbiome supplementation as therapy for metabolic syndrome. World J Diabetes 2023; 14(10): 1502-1513
URL: https://www.wjgnet.com/1948-9358/full/v14/i10/1502.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i10.1502